MMR-deficient News
Latest articles and news about MMR-deficient on AXL Media.
Latest Articles
- UCL NEOPRISM-CRC Trial Reports Zero Relapses for Bowel Cancer Patients Using Pre-Op Immunotherapy
Published: Apr 21, 2026
Section: Medical News
Long-term results from the NEOPRISM-CRC clinical trial show that a short course of pembrolizumab immunotherapy before surgery has kept 100% of high-risk bowel cancer patients cance...
- Zero Relapse Rate Reported in UCL Trial Using Pre-Operative Immunotherapy for High-Risk Bowel Cancer
Published: Apr 21, 2026
Section: Medical News
The NEOPRISM-CRC clinical trial, led by University College London (UCL) and UCLH, has demonstrated a remarkable 100% cancer-free rate after three years for patients with specific h...